Drug intelligence / Profile preview

Yiqi Jiedu Tongluo Fang

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Yiqi Jiedu Tongluo Fang (益气解毒通络方) is a traditional Chinese medicine (TCM) herbal formula used primarily as an adjunct therapy in the treatment of advanced cancers, especially non-small cell lung cancer (NSCLC), and for its potential benefits in diabetic retinopathy. The formula is based on TCM principles of "tonifying qi," "removing toxins," and "unblocking collaterals." It aims to address the TCM pathogenesis of deficiency, stasis, and toxin that are believed to underlie tumor progression. Clinical studies suggest it may improve patient quality of life, enhance efficacy and reduce toxicity when combined with chemotherapy or targeted therapies such as EGFR-TKIs in NSCLC patients[7][2]. In preclinical models, it has shown antioxidant and anti-inflammatory effects, improved glucose metabolism, protected retinal structure/function via modulation of pathways including p38 MAPK and VEGFR signaling[6]. The precise herbal composition can vary but typically includes herbs with functions to tonify qi (vital energy), activate blood circulation, detoxify the body, and unblock meridians.

Other names
益气解毒通络方
02

Targets

RK (Ribokinase)VEGFR (VEGFR family)

Beyond the preview

Go deeper on Yiqi Jiedu Tongluo Fang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yiqi Jiedu Tongluo Fang.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call